Pfizer’s Shares Rose in Premarket Trading After an Israeli Report
An Israeli study stated that Pfizer’s booster shots of the Covid-19 vaccine were effective against the Omicron variant. As a result of the news, Pfizer saw their shares rise.
FDA Panel Voted Unanimously for Johnson and Johnson’s Booster Shot
10/15/2021-The FDA panel has voted unanimously in support of the Johnson and Johnson booster shot for all Americans, who 2 months before got the first shot.
FDA Panel Recommend Moderna Booster for Elderly and High Risk Adults
10/14/2021-An FDA advisory panel voted to recommend a booster shot of the Moderna Coronavirus vaccine for the elderly and high risk adults.
FDA Questioned the Strength of the Johnson and Johnson Booster
10/13/2021-The FDA questioned the strength of the evidence that Johnson and Johnson provided for their Covid-19 booster shot. They believe that the test used by the company wasn’t sensitive enough,…